The Food and Drug Administration has played a large role in the COVID-19 response and is also amid widespread digital transformation. Chief Technology Officer Vid Desai joined the agency two years ago and brings private-sector experience from the health technology industry. Desai observes the similarities of FDA’s tech focus with those in his private industry experiences, discusses how he’s driving change from a business perspective to meet the mission, and shares examples of how innovation in data can unlock efficiencies and opportunities for medical devices and the public.
-
Vid Desai Chief Technology Officer FDA
Related Content
-
Streamlining the ATO Process Makes Software Deployments More Efficient, Secure
NIST’s Victoria Yan Pillitteri discusses common ATO stumbling blocks and how agencies can streamline authorization for secure software deployment.
7m watch -
This National Lab is Using Multi-Agent AI to Accelerate Scientific Discovery
SLAC’s John Sarrao details how AI is accelerating materials discovery and reshaping collaboration across national labs and federal agencies.
21m watch -
NIAID CIO: AI Expands Multidimensional Biomedical Data Analysis
AI tools provide new ways to integrate and examine biomedical data for the government's allergy and infectious diseases research agency.
2m read -
Open Data Fabric Coming to CMS, But Culture Remains a Barrier
CMS and NIH officials discuss hybrid multi-cloud strategies and cultural barriers to open health data sharing.
2m read
